{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:42:21Z","timestamp":1789756941671,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["Y231N00236"],"award-info":[{"award-number":["Y231N00236"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction and Hypothesis<\/jats:title>\n            <jats:p>Since 2018 we have offered polyacrylamide hydrogel (PAHG) injection as an alternative to tension-free vaginal tape (TVT) for primary stress urinary incontinence (SUI). Our study aim was to investigate patient choice, demographics, re-treatments, and complications for these procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patient demographics were collected from the Hospital Registry for women with primary SUI treated with TVT or PAHG, including patient age, body mass index, smoking status, obstetric history, and prior pelvic surgeries. Re-treatments and complications were collected at 2-year follow-up after each primary procedure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 391 primary procedures, 55% (<jats:italic>n<\/jats:italic> = 217) of women chose the TVT and 45% (<jats:italic>n<\/jats:italic> = 174) the PAHG treatment, with similar patient demographics. Within 2 years, the re-treatment rates were 0.9% (<jats:italic>n<\/jats:italic> = 2) for TVT and 27.0% (<jats:italic>n<\/jats:italic> = 47) for PAHG (<jats:italic>p<\/jats:italic> &lt; 0.001). Among patients undergoing re-treatment after primary PAHG, 57.4% (<jats:italic>n<\/jats:italic> = 27) opted for re-injection and 42.6% (<jats:italic>n<\/jats:italic> = 20) chose a mid-urethral sling. Three patients received TVT after two PAHG injection treatments. Complications occurred in 14.3% and 9.2% after TVT and PAHG respectively (<jats:italic>p<\/jats:italic> = 0.124). Complications after TVT ranged from Clavien\u2013Dindo grades I\u2013IIIb, with 4.1% of patients requiring reoperations, whereas PAHG complications were grades I\u2013II with no reoperations. Including re-treatments, complication rates were 14.3% (TVT) and 10.9% (PAHG; <jats:italic>p<\/jats:italic> = 0.322).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Similar clinical profiles in both TVT and PAHG groups suggest no specific demographic factors predict decision making. After a 2-year follow-up, the overall complication rates were similar, with PAHG associated with a higher likelihood of requiring re-treatment, whereas TVT carried a greater risk of severe complications. The re-treatment rates were lower than previously reported, indicating that actual patients are fairly satisfied with their primary choice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00192-025-06119-9","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:41:44Z","timestamp":1744080104000},"page":"895-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tension-Free Vaginal Tape versus Polyacrylamide Hydrogel Bulking Agent for Stress Urinary Incontinence: Patient Choice and Outcomes in Finland"],"prefix":"10.1007","volume":"36","author":[{"given":"Lotta","family":"S\u00e4rkilahti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-088X","authenticated-orcid":false,"given":"Tomi S.","family":"Mikkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"6119_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-1-35","volume":"1","author":"BA Broome","year":"2003","unstructured":"Broome BA. The impact of urinary incontinence on self-efficacy and quality of life. Health Qual Life Outcomes. 2003;1:35. https:\/\/doi.org\/10.1186\/1477-7525-1-35.","journal-title":"Health Qual Life Outcomes."},{"issue":"2","key":"6119_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01902378","volume":"7","author":"U Ulmsten","year":"1996","unstructured":"Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):81\u20135. https:\/\/doi.org\/10.1007\/BF01902378; discussion 85\u20136.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"8","key":"6119_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00192-013-2090-2","volume":"24","author":"CG Nilsson","year":"2013","unstructured":"Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C. Seventeen years\u2019 follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013;24(8):1265\u20139. https:\/\/doi.org\/10.1007\/s00192-013-2090-2.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"6119_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00192-019-04223-1","volume":"31","author":"S Tulokas","year":"2020","unstructured":"Tulokas S, Rahkola-Soisalo P, Gissler M, Mikkola TS, Mentula MJ. Long-term re-procedure rate after mid-urethral slings for stress urinary incontinence. Int Urogynecol J. 2020;31(4):727\u201335. https:\/\/doi.org\/10.1007\/s00192-019-04223-1.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6119_CR5","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/s41598-017-11821-w","volume":"7","author":"K Keltie","year":"2017","unstructured":"Keltie K, Elneil S, Monga A, Patrick H, Powell J, Campbell B, Sims AJ. Complications following vaginal mesh procedures for stress urinary incontinence: an 8-year study of 92,246 women. Sci Rep. 2017;7(1):12015. https:\/\/doi.org\/10.1038\/s41598-017-11821-w.","journal-title":"Sci Rep"},{"issue":"2","key":"6119_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/JU.0000000000000517","volume":"203","author":"AM Itkonen Freitas","year":"2020","unstructured":"Itkonen Freitas AM, Mentula M, Rahkola-Soisalo P, Tulokas S, Mikkola TS. Tension-free vaginal tape surgery versus polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomized clinical trial. J Urol. 2020;203(2):372\u20138. https:\/\/doi.org\/10.1097\/JU.0000000000000517.","journal-title":"J Urol"},{"issue":"3","key":"6119_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/JU.0000000000002720","volume":"208","author":"AM Itkonen Freitas","year":"2022","unstructured":"Itkonen Freitas AM, Isaksson C, Rahkola-Soisalo P, Tulokas S, Mentula M, Mikkola TS. Tension-free vaginal tape and polyacrylamide hydrogel injection for primary stress urinary incontinence: 3-year follow-up from a randomized clinical trial. J Urol. 2022;208(3):658\u201367. https:\/\/doi.org\/10.1097\/JU.0000000000002720.","journal-title":"J Urol"},{"issue":"4","key":"6119_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00192-019-04202-6","volume":"31","author":"L Dwyer","year":"2020","unstructured":"Dwyer L, Weaver E, Rajai A, Cox S, Reid F. \u201cVoice your choice\u201d: a study of women\u2019s choice of surgery for primary stress urinary incontinence. Int Urogynecol J. 2020;31(4):769\u201377. https:\/\/doi.org\/10.1007\/s00192-019-04202-6.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"6119_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1590\/S1677-55382006000500014","volume":"32","author":"SP Petrou","year":"2006","unstructured":"Petrou SP, Lisson SW, Crook JE, Lightner DJ. An exploration into patient preference for injectable therapy over surgery in the treatment of female urinary incontinence. Int Braz J Urol. 2006;32(5):578\u201382. https:\/\/doi.org\/10.1590\/S1677-55382006000500014.","journal-title":"Int Braz J Urol"},{"issue":"9","key":"6119_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00192-018-3644-0","volume":"29","author":"FM Casteleijn","year":"2018","unstructured":"Casteleijn FM, Zwolsman SE, Kowalik CR, Roovers JPWR. Patients\u2019 perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence. Int Urogynecol J. 2018;29(9):1249\u201357. https:\/\/doi.org\/10.1007\/s00192-018-3644-0.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"6119_CR11","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00192-023-05510-8","volume":"34","author":"EMV Goessens","year":"2023","unstructured":"Goessens EMV, Cammu H. A 10- to 20-year follow-up after tension-free vaginal tape for stress urinary incontinence. Int Urogynecol J. 2023;34(9):2107\u201314. https:\/\/doi.org\/10.1007\/s00192-023-05510-8.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6119_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/nau.24589","volume":"40","author":"T Brosche","year":"2021","unstructured":"Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40(1):502\u20138. https:\/\/doi.org\/10.1002\/nau.24589.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"6119_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3109\/00016349609055032","volume":"75","author":"A Klovning","year":"1996","unstructured":"Klovning A, Hunskaar S, Eriksen BC. Validity of a scored urological history in detecting detrusor instability in female urinary incontinence. Acta Obstet Gynecol Scand. 1996;75(10):941\u20135. https:\/\/doi.org\/10.3109\/00016349609055032.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"6119_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/003655901753367587","volume":"35","author":"B Stach-Lempinen","year":"2001","unstructured":"Stach-Lempinen B, Kujansuu E, Laippala P, Mets\u00e4noja R. Visual analogue scale, urinary incontinence severity score and 15 D\u2014psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women. Scand J Urol Nephrol. 2001;35(6):476\u201383. https:\/\/doi.org\/10.1080\/003655901753367587.","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"6119_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.SLA.0000133083.54934.AE","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.SLA.0000133083.54934.AE.","journal-title":"Ann Surg"},{"issue":"12","key":"6119_CR16","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/aogs.14271","volume":"100","author":"R Svenningsen","year":"2021","unstructured":"Svenningsen R, Oversand SH, Schi\u00f8tz HA, Kulseng-Hanssen S. Comparing risk of repeat surgery for stress urinary incontinence after mid-urethral slings and polyacrylamide hydrogel. Acta Obstet Gynecol Scand. 2021;100(12):2186\u201392. https:\/\/doi.org\/10.1111\/aogs.14271.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"16","key":"6119_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2018.14997","volume":"320","author":"I Gurol-Urganci","year":"2018","unstructured":"Gurol-Urganci I, Geary RS, Mamza JB, Duckett J, El-Hamamsy D, Dolan L, et al. Long-term rate of mesh sling removal following midurethral mesh sling insertion among women with stress urinary incontinence. JAMA. 2018;320(16):1659\u201369. https:\/\/doi.org\/10.1001\/jama.2018.14997.","journal-title":"JAMA"},{"issue":"6","key":"6119_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/nau.24696","volume":"40","author":"V Hoe","year":"2021","unstructured":"Hoe V, Haller B, Yao HH, O\u2019Connell HE. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40(6):1349\u201388. https:\/\/doi.org\/10.1002\/nau.24696.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"6119_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00192-015-2781-y","volume":"27","author":"AD Kasi","year":"2016","unstructured":"Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid\u00ae) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27(3):367\u201375. https:\/\/doi.org\/10.1007\/s00192-015-2781-y.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"6119_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/aogs.12283","volume":"93","author":"L Mouritsen","year":"2014","unstructured":"Mouritsen L, Lose G, M\u00f8ller-Bek K. Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence. Acta Obstet Gynecol Scand. 2014;93(2):209\u201312. https:\/\/doi.org\/10.1111\/aogs.12283.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"6119_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.urology.2010.10.010","volume":"77","author":"ME Koski","year":"2011","unstructured":"Koski ME, Enemchukwu EA, Padmanabhan P, Kaufman MR, Scarpero HM, Dmochowski RR. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection. Urology. 2011;77(5):1076\u201380. https:\/\/doi.org\/10.1016\/j.urology.2010.10.010.","journal-title":"Urology"},{"issue":"2","key":"6119_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SPV.0000000000001319","volume":"29","author":"A Arthur","year":"2023","unstructured":"Arthur A, Guaderrama NM, Zhang J, Chung J, Whitcomb EL. Retreatment of stress urinary incontinence after midurethral sling with prior urethral bulking. Urogynecology (Phila). 2023;29(2):133\u20138. https:\/\/doi.org\/10.1097\/SPV.0000000000001319.","journal-title":"Urogynecology (Phila)"},{"issue":"5","key":"6119_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/AOG.0000000000003526","volume":"134","author":"AA Berger","year":"2019","unstructured":"Berger AA, Tan-Kim J, Menefee SA. Long-term risk of reoperation after synthetic mesh midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2019;134(5):1047\u201355. https:\/\/doi.org\/10.1097\/AOG.0000000000003526.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"6119_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00192-017-3278-7","volume":"28","author":"ZA Siddiqui","year":"2017","unstructured":"Siddiqui ZA, Abboudi H, Crawford R, Shah S. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2017;28(9):1275\u201384. https:\/\/doi.org\/10.1007\/s00192-017-3278-7.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"6119_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/nau.22584","volume":"34","author":"KD Clement","year":"2015","unstructured":"Clement KD, Lapitan MC, Omar MI, Glazener CM. Urodynamic studies for management of urinary incontinence in children and adults: a short version Cochrane systematic review and meta-analysis. Neurourol Urodyn. 2015;34(5):407\u201312. https:\/\/doi.org\/10.1002\/nau.22584.","journal-title":"Neurourol Urodyn"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06119-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T01:02:47Z","timestamp":1746838967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06119-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6119"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06119-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of the Hospital District of Helsinki and Uusimaa (HUS\/117\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"L. S\u00e4rkilahti has received research grants from Helsinki University Hospital and Finska L\u00e4kares\u00e4llskapet during the study period. The funding sources did not influence the study\u2019s design, conduct, or reporting. T.S. Mikkola has received lecture fees from Astellas, Axonics and Mylan. C. Isaksson reports no financial disclaimers or conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclaimers\/Conflicts of Interest"}}]}}